Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2020-04-09 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
COVID-19 Consortium MOU
Regulatory Filings Classification · 1% confidence The document is a regulatory news announcement (RNS) issued by Omega Diagnostics Group PLC regarding a Memorandum of Understanding (MOU) for a COVID-19 consortium. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general corporate announcement distributed via the London Stock Exchange's RNS service, it falls under the 'Regulatory Filings' category.
2020-04-09 English
VISITECT® CD4 Advanced Disease evaluation
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 2,500 characters) issued via the London Stock Exchange's RNS (Regulatory News Service). It informs the market about the publication of a third-party research study regarding the company's product (VISITECT CD4) and provides a link to the external study. It does not contain the report itself, but rather announces its existence and availability, fitting the criteria for a Regulatory Filing (RNS) as it is a general corporate announcement that does not fall into more specific categories like financial reports or board changes.
2020-04-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This specific document details that Oryx International Growth Fund Limited has crossed a threshold in Omega Diagnostics Group PLC. This falls directly under the 'Major Shareholding Notification' category.
2020-04-06 English
Chinese Approval for Food Detective® test
Regulatory Filings Classification · 1% confidence The document is a regulatory news announcement (RNS) issued by Omega Diagnostics Group PLC regarding the approval of their 'Food Detective' test in China. It does not fit into specific categories like financial reports, dividends, or board changes, and is a standard corporate news update disseminated via the London Stock Exchange's RNS service. Therefore, it falls under the 'Regulatory Filings' category.
2020-04-02 English
Trading Update
Earnings Release Classification · 1% confidence The document is a 'Trading Update' issued by Omega Diagnostics Group PLC via the London Stock Exchange's RNS (Regulatory News Service). It provides preliminary financial expectations (EBITDA range) and operational updates regarding product testing and the impact of the coronavirus pandemic ahead of the final results. Since it is an initial announcement of financial performance highlights rather than the full audited annual report, it is classified as an Earnings Release (ER). FY 2020
2020-04-02 English
Grant of Options under Company EMI Plan
Director's Dealing Classification · 1% confidence The document is an official notification regarding the grant of share options to company directors and persons discharging managerial responsibilities (PDMRs). It includes detailed tables of the transactions and follows the standard format for Director's Dealing (DIRS) notifications under the Market Abuse Regulation (MAR).
2020-01-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.